Nitric oxide activity and isoenzyme expression in the senescence- accelerated mouse P8 model of Alzheimer's disease: Effects of anti-amyloid antibody and antisense treatments

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 10, 2009, Pages 1025-1030

  Ali, Abbas K ^b   Banks, William A ^a   Kumar, Vijaya B ^b   Shah, Gul N ^b   Lynch, Jessica L ^b   Farr, Susan A ^b   Fleegal DeMotta, Melissa A ^b   Morley, John E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Alzheimer's disease; Amyloid beta protein; Antibody; Antisense; mRNA; Nitric oxide; Nitric oxide synthase; SAMP8

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOENZYME; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISENSE THERAPY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE ACCELERATED MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; ANTISENSE ELEMENTS (GENETICS); DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IMMUNOLOGIC FACTORS; ISOENZYMES; MALE; MICE; NITRIC OXIDE SYNTHASE; RNA, MESSENGER;

MUS;

EID: 69949108880     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/glp074     Document Type: Article

References (44)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 Census. Arch Neurol. 2003;60:1119-1122.
2. Rosenberg RN. The molecular and genetic basis of AD: the end of the beginning. The 2000 Wartenberg lecture. Neurology. 2000;54:2045-2054.
3. Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell. 2007;13:215-221.
4. Butterfield DA, Kanski J. Review: methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42. Peptides. 2002;23:1299-1309. (Pubitemid 34786708)
5. Koppal T, Drake J, Yatin S, et al. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J Neurochem. 1999;72:310-317. (Pubitemid 29013906)
6. Bohme GA, Bon C, Lemaire M, et al. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci U S A. 1993;90:9191-9194. (Pubitemid 23306478)
7. Arnaiz SL, D'Amico G, Paglia N, Arismendi M, Basso N, del Rosario Lores Arnaisz M. Enriched environment, nitric oxide production and synaptic plasticity prevent the aging-dependent impairment of spatial cognition. Mol Aspects Med. 2004;25:91-101. (Pubitemid 38401934)
8. Edwards TM, Rickard NS. New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes. Neurosci Biobehav Rev. 2007;31:413-425.
9. Wultsch T, Chourbaji S, Fritzen S, et al. Behavioral and expressional phenotyping of nitric oxide synthase-1 knockdown animals. J Neural Transm Suppl. 2007;69-85.
10. Frisch C, Dere E, Silva MA, Godecke A, Schrader J, Huston JP. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci. 2000;20:6694-6700. (Pubitemid 30834284)
11. Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett. 2002;322:121-125. (Pubitemid 34212035)
12. Heneka MT, Wiesinger H, Dumitrescu-Ozimek L, Riederer P, Feinstein DL, Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer's disease. J Neuropathol Exp Neurol. 2001;60:9-16. (Pubitemid 32880598)
13. Dorheim MA, Tracey WR, Pollock JS, Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun. 1994;205:659-665. (Pubitemid 24381677)
14. Munoz-Fernandez MA, Fresno M. The role of tumor necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. 1998;56:307-340. (Pubitemid 28389722)
15. Akama KT, Van Eldik LJ. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem. 2000;275:7918-7924.
16. Zeng C, Lee JT, Chen H, Chen S, Hsu CY, Xu J. Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. J Neurochem. 2005;94:703-712. (Pubitemid 41098502)
17. Jang JH, Surh YJ. AP-1 mediates beta-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways. Biochem Biophys Res Commun. 2005;331:1421-1428.
18. Cho JY, Kim HS, Kim DH, Yan JJ, Suh HW, Song DK. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:901-907.
19. Keil U, Bonert A, Marques CA, et al. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem. 2004;279:50310-50320. (Pubitemid 39577847)
20. Ma G, Chen S. Diazoxide and N omega-nitro-L-arginine counteracted A beta 1-42-induced cytotoxicity. Neuroreport. 2004;15:1813-1817. (Pubitemid 39062601)
21. Wang Q, Rowan MJ, Anwyl R. Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J Neurosci. 2004;24:6049-6056. (Pubitemid 38891095)
22. Gentile MT, Vecchione C, Maffei A, et al. Mechanisms of soluble beta-amyloid impairment of endothelial function. J Biol Chem. 2004;279:48135-48142. (Pubitemid 39540968)
23. Suhara T, Magrane J, Rosen K, et al. Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3beta signaling-dependent mechanism. Neurobiol Aging. 2003;24:437-457. (Pubitemid 36205050)
24. de la Torre JC, Pappas BA, Prevot V, et al. Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats. Neurol Res. 2003;25:635-641. (Pubitemid 37087608)
25. Rodriguez MI, Escames G, Lopez LC, Garcia JA, Ortiz F, Acuna- Castroviejo D. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res. 2007;42:272-279. (Pubitemid 46365065)
26. Inada K, Yokoi I, Kabuto H, Habu H, Mori A, Ogawa N. Age-related increase in nitric oxide synthase activity in senescence accelerated mouse brain and the effect of long-term administration of superoxide radical scavenger. Mech Ageing Dev. 1996;89:95-102. (Pubitemid 26248832)
27. Morley JE, Farr SA, Kumar VB, Banks WA. Alzheimer's disease through the eye of a mouse. Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize. Peptides. 2002;23:589-599.
28. Farr SA, Banks WA, Uezu K, Sano A, Gaskin FS, Morley JE. Antibody to beta-amyloid protein increases acetylcholine in the hippocampus of 12 month SAMP8 male mice. Life Sci. 2003;73:555-562. (Pubitemid 36589035)
29. Kumar VB, Farr SA, Flood JF, et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000;21:1769-1775.
30. Farr SA, Poon HF, Dogrukol-Ak D, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173-1183. (Pubitemid 36330669)
31. Poon HF, Joshi G, Sultana R, et al. Antisense directed at the A-beta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res. 2004;1018:86-96. (Pubitemid 38942865)
32. Poon HF, Farr SA, Thongboonkerd V, et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int. 2005;46:159-168. (Pubitemid 41556623)
33. Kumar VB, Bernardo AE, Alshaher MM, Buddhiraju M, Purushothaman R, Morley JE. Rapid assay for nitric oxide synthase using thin-layer chromatography. Anal Biochem. 1999;269:17-20. (Pubitemid 29174257)
34. Inada K, Yokoi I, Kabuto H, Namba Y, Ogawa N. The effects of chronic administration of nimodipine on age-related changes in nitric oxide and its synthase in senescence-accelerated mouse brain. Biochem Mol Biol Int. 1997;41:753-765. (Pubitemid 27182709)
35. Colas D, Gharib A, Bezin L, et al. Regional age-related changes in neuronal nitric oxide synthase (nNOS) messenger RNA levels and activity in SAMP8 brain [Abstract]. BMC Neurosci. 2006;7:81. (Pubitemid 46178873)
36. Morley JE, Kumar VB, Bernardo AF, et al. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 2000;21:1761-1767.
37. Pak T, Cadet P, Mantione KJ, Stefano GB. Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease. Med Sci Monit. 2005;11: BR357-BR366. (Pubitemid 41482727)
38. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med. 2001;7:548-554. (Pubitemid 33127140)
39. Mark RJ, Hensley K, Butterfield DA, Mattson MP. Amyloid β-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J Neurosci. 1995;15:6239-6249.
40. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem. 2000;275:5626-5632.
41. Ricchelli F, Drago D, Filippi B, Tognon G, Zatta P. Aluminum-triggered structural modifications and aggregation of β-amyloids. A comparison with copper and zinc. CellMol Life Sci. 2005;62:1724-1733.
42. Farr SA, Uezu K, Flood JF, Morley JE. Septo-hippocampal drug interactions in post-trial memory processing. Brain Res. 1999;847:221-230.
43. Flood JF, Harris FJ, Morley JE. Age-related changes in hippocampal drug facilitation of memory processing in SAMP8 mice. Neurobiol Aging. 1996;17:15-24.
44. Morley JE, Farr SA, Johnson SN, Banks WA. The presence of amyloid β protein in CD-1 mice is important for learning. Soc Neurosci Abstracts. 2005;199.13